longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BMGL

BMGL
----

LongbridgeAI

U.S. stock market update: Hims & Hers Health up 3.49%

Price Alert
Jul 9, 2025 at 05:02 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Hims & Hers Health rose 3.49%; Basel Medical rose 70.87%, with a transaction volume of USD 218 million; CVS Health fell 0.83%, with a transaction volume of USD 178 million and a market value of USD 84 billion; Cigna fell 0.98%, with a transaction volume of USD 123 million

U.S. Stock Market Midday Update

Hims & Hers Health rose 3.49%. Based on recent important news:

  1. On July 9, Hims & Hers Health announced plans to enter the Canadian market next year, with the stock price rising over 6% at one point. The company plans to offer low-cost treatment options through its digital platform.

  2. On July 9, Hims & Hers Health's CFO Oluyemi Okupe sold company stock totaling $540,498.

  3. On July 8, Hims & Hers Health faced multiple class-action lawsuits involving potential violations of securities laws.

Stocks with High Trading Volume in the Industry

Basel Medical rose 70.87%, with a trading volume of $218 million. Based on recent important news:

  1. On June 12, executives from a Chinese biopharmaceutical company revealed at the Goldman Sachs Global Healthcare Conference that a significant external licensing deal would soon be finalized, driving the company's stock price up nearly 18%.

  2. On June 26, Yaojie Ankang-B surged nearly 5% in the closing hours, reaching HKD 26.2, doubling from its IPO price, with a trading volume of HKD 29.2565 million.

  3. On July 2, Minglida had a block trade of 6.651 million shares, with a trading volume of CNY 96.9051 million, accounting for 61.59% of the total trading volume that day, at a discount of 20.34%.

CVS Health fell 0.83%, with increased trading volume. Based on recent important news:

  1. On July 9, a federal judge ruled that CVS Health's Omnicare division must pay nearly $949 million in fines for allegedly submitting false drug claims between 2010 and 2018, causing the stock price to drop.

  2. On July 7, CVS announced a quarterly dividend of $0.665 per share, failing to boost market confidence.

  3. On July 8, analysts rated CVS as a moderate buy but believed that five other stocks offered better investment value.

Cigna fell 0.98%, with increased trading volume. Based on recent important news:

  1. On July 8, the Cigna Foundation announced a $3 million grant for mental health and housing stability for veterans, which did not have a direct impact on the stock price.

  2. On July 7, the Hong Kong real estate market was active, which did not directly affect Cigna's stock price.

  3. On July 7, the International Court of Justice is set to release opinions related to the Paris Agreement on July 23, which did not have a direct impact on Cigna.

Stocks with High Market Capitalization in the Industry

CVS Health fell 0.83%, with increased trading volume. Based on recent important news:

  1. On July 9, a federal judge ordered CVS to pay nearly $949 million in fines related to false claims involving its Omnicare unit, causing the stock price to drop

  2. On July 7th, CVS announced a quarterly dividend of $0.665 per share, which failed to boost the stock price.

  3. On July 8th, analysts stated that CVS is not on the recommended buy list, affecting market confidence

Login to unlock2,357characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 9, 2026 at 09:04 PMNovo Nordisk's weight loss drug advertisement was deemed "false or misleading" by the FDA, and the stock price hit a new…
  • Feb 6, 2026 at 09:33 PMFDA warns of "swift action," HIMS weight loss drug generic plan thwarted, stock price falls nearly 6%
  • Feb 5, 2026 at 11:09 PMNovo Nordisk plummeted 8%, as the new weight loss pill faced "knockoffs" right after its launch, with telemedicine compa…

Related Stocks

Hims & Hers Health

Hims & Hers Health

USHIMS

-0.28%

Basel Medical

Basel Medical

USBMGL

-10.66%

CVS Health

CVS Health

USCVS

-0.85%